Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA Starts Over In CEO Search After Tauzin Negotiations End

This article was originally published in The Pink Sheet Daily

Executive Summary

Louisiana Republican breaks off negotiations with trade association amid negative media attention. Rep. Joe Barton will take the helm of the Energy & Commerce Committee.

You may also be interested in...



PhRMA CEO Selection Day Nears Now That Election Day Is Past

Trade association board is expected to finalize choice to succeed CEO Alan Holmer during Nov. 11-12 strategy session. Rep. Billy Tauzin (R-La.) is still viewed as the likely pick.

PhRMA CEO Selection Day Nears Now That Election Day Is Past

Trade association board is expected to finalize choice to succeed CEO Alan Holmer during Nov. 11-12 strategy session. Rep. Billy Tauzin (R-La.) is still viewed as the likely pick.

BIO Top Job May Go To Rep. Greenwood

Oversight Subcommittee chairman confirms he is considering leaving Congress to pursue a new opportunity, but says he will have no further comment until he makes a decision "in the very near future." Greenwood has been among most active legislators on pharmaceutical issues, and has worked with BIO on stem cell and human subject protection proposals.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058715

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel